Signal Peptide Website
Search my Protein
Advanced Search
Database Search
References
Hints
Links
Imprint
Signal Peptide Database - Viruses
Entry Details
ID
1823
Source Database
UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number
Q9QAR5 (Created: 2007-04-17 Updated: 2008-11-25)
UniProtKB/Swiss-Prot Entry Name
SPIKE_CVBLS
Protein Name
Spike glycoprotein
Gene
S
Organism Scientific
Bovine coronavirus (strain LSU-94LSS-051)
Organism Common
BCoV-LSU
Lineage
Viruses
ssRNA positive-strand viruses, no DNA stage
Nidovirales
Coronaviridae
Coronavirus
Coronavirus group 2
Coronavirus group 2a
Protein Length [aa]
1363
Protein Mass [Da]
150515
Features
Type
Description
Status
Start
End
signal peptide
potential
1
17
chain
Spike glycoprotein
18
1363
chain
Spike protein S1
potential
18
768
chain
Spike protein S2
potential
769
1363
transmembrane region
potential
1312
1328
topological domain
Extracellular
potential
18
1311
topological domain
Cytoplasmic
potential
1329
1363
region of interest
Heptad repeat 1
potential
1043
1086
region of interest
Heptad repeat 2
potential
1267
1297
glycosylation site
N-linked (GlcNAc...)
potential
59
59
glycosylation site
N-linked (GlcNAc...)
potential
133
133
glycosylation site
N-linked (GlcNAc...)
potential
198
198
glycosylation site
N-linked (GlcNAc...)
potential
359
359
glycosylation site
N-linked (GlcNAc...)
potential
437
437
glycosylation site
N-linked (GlcNAc...)
potential
649
649
glycosylation site
N-linked (GlcNAc...)
potential
676
676
glycosylation site
N-linked (GlcNAc...)
potential
696
696
glycosylation site
N-linked (GlcNAc...)
potential
714
714
glycosylation site
N-linked (GlcNAc...)
potential
739
739
glycosylation site
N-linked (GlcNAc...)
potential
788
788
glycosylation site
N-linked (GlcNAc...)
potential
937
937
glycosylation site
N-linked (GlcNAc...)
potential
1194
1194
glycosylation site
N-linked (GlcNAc...)
potential
1224
1224
glycosylation site
N-linked (GlcNAc...)
potential
1234
1234
glycosylation site
N-linked (GlcNAc...)
potential
1253
1253
glycosylation site
N-linked (GlcNAc...)
potential
1267
1267
glycosylation site
N-linked (GlcNAc...)
potential
1288
1288
site
Cleavage; by host
potential
768
769
compositionally biased region
Cys-rich
1329
1346
coiled-coil region
potential
1043
1087
coiled-coil region
potential
1269
1297
SP Length
17
----+----1----+----2----+----3----+----4----+----5
Signal Peptide
MFLILLISLPTAFAVIG
Sequence
MFLILLISLPTAFAVIG
DLKCTTVSINDVDTGVPSISTDTVDVTNGLGTY
YVLDRVYL
N
TTLLLNGYYPTSGSTYRNMALKGTLLLSTLWFKPPFLSDFT
NGIFAKVKNTKVIKDGVKYSEFPAITIGSTFV
N
TSYSVVVQPHTTNLDNK
LQGLLEISVCQYTMCEYPNTICNPNLGNQRVELWHWDTGVVSCLYKR
N
FT
YDVNADYLYFHFYQEGGTFYAYFTDTGVVTKFLFNVYLGTVLSHYYVMPL
TCNSALTLEYWVTPLTSKQYLLAFNQDGVIFNAVDCKSDFMSEIKCKTLS
IAPSTGVYELNGYTVQPIADVYRRIPNLPDCNIEAWLNDKSVPSPLNWER
KTFSNCNF
N
MSSLMSFIQADSFTCNNIDAAKIYGMCFSSITIDKFAIPNG
RKVDLQLGNLGYLQSFNYRIDTTATSCQLYYNLPAA
N
VSVSRFNPSTWNR
RFGFTEQSVFKPQPAGVFTDHDVVYAQHCFKAPTNFCPCKLDGSLCVGSG
SGIDAGYKNTGIGTCPAGTNYLTCHNAAQCGCLCTPDPITSKATGPYKCP
QTKYLVGIGEHCSGLAIKSDYCGGNPCSCQPQAFLGWSVDSCLQGDRCNI
FANFILHDVNSGTTCSTDLQKSNTDIILGVCVNYDLYGITGQGIFVEV
N
A
TYYNSWQNLLYDSNGNLYGFRDYLT
N
RTFMIRSCYSGRVSAAFHA
N
SSEP
ALLFRNFKCNYVF
N
NTLSRQLQPINYFDSYLGCVVNAD
N
STSSVVQTCDL
TVGSGYCVDYSTKRRSR
RS
ITTGYRFTNFEPFTVNSV
N
DSLEPVGGLYEI
QIPSEFTIGNMEEFIQTSSPKVTIDCSAFVCGDYAACKSQLVEYGSFCDN
INAILTEVNELLDTTQLQVANSLMNGVTLSTKLKDGVNFNVDDINFSPVL
GCLGSDCNKVSSRSAIEDLLFSKVKLSDVGFVEAYN
N
CTGGAEIRDLICV
QSYNGIKVLPPLLSENQISGYTLAATSASLFPPWSAAAGVPFYLNVQYRI
NGIGVTMDVLSQNQKLIANAFNNALGAIQEGFDATNSALVKI
QAVVNANA
EALNNLLQQLSNRFGAISSSLQEILSRLDALEAQAQI
DRLINGRLTALNA
YVSQQLSDSTLVKFSAAQAMEKVNECVKSQSSRINFCGNGNHIISLVQNA
PYGLYFIHFSYVPTKYVTAKVSPGLCIAGDRGIAPKSGYFVNV
N
NTWMFT
GSGYYYPEPITGNNVVVMSTCAV
N
YTKAPDVML
N
ISTPNLPDFKEELDQW
FK
N
QTSVAPDLSLDYI
N
V
TFLDLQDEMNRLQEAIKVLNQSYINLKDI
GTY
EYYVKWPWYVW
LLIGFAGVAMLVLLFFI
CCCTGCGTSCFKKCGGCC
DDYT
GHQELVIKTSHDD
Original
MFLILLISLPTAFAVIGDLKCTTVSINDVDTGVPSISTDTVDVTNGLGTY
YVLDRVYLNTTLLLNGYYPTSGSTYRNMALKGTLLLSTLWFKPPFLSDFT
NGIFAKVKNTKVIKDGVKYSEFPAITIGSTFVNTSYSVVVQPHTTNLDNK
LQGLLEISVCQYTMCEYPNTICNPNLGNQRVELWHWDTGVVSCLYKRNFT
YDVNADYLYFHFYQEGGTFYAYFTDTGVVTKFLFNVYLGTVLSHYYVMPL
TCNSALTLEYWVTPLTSKQYLLAFNQDGVIFNAVDCKSDFMSEIKCKTLS
IAPSTGVYELNGYTVQPIADVYRRIPNLPDCNIEAWLNDKSVPSPLNWER
KTFSNCNFNMSSLMSFIQADSFTCNNIDAAKIYGMCFSSITIDKFAIPNG
RKVDLQLGNLGYLQSFNYRIDTTATSCQLYYNLPAANVSVSRFNPSTWNR
RFGFTEQSVFKPQPAGVFTDHDVVYAQHCFKAPTNFCPCKLDGSLCVGSG
SGIDAGYKNTGIGTCPAGTNYLTCHNAAQCGCLCTPDPITSKATGPYKCP
QTKYLVGIGEHCSGLAIKSDYCGGNPCSCQPQAFLGWSVDSCLQGDRCNI
FANFILHDVNSGTTCSTDLQKSNTDIILGVCVNYDLYGITGQGIFVEVNA
TYYNSWQNLLYDSNGNLYGFRDYLTNRTFMIRSCYSGRVSAAFHANSSEP
ALLFRNFKCNYVFNNTLSRQLQPINYFDSYLGCVVNADNSTSSVVQTCDL
TVGSGYCVDYSTKRRSRRSITTGYRFTNFEPFTVNSVNDSLEPVGGLYEI
QIPSEFTIGNMEEFIQTSSPKVTIDCSAFVCGDYAACKSQLVEYGSFCDN
INAILTEVNELLDTTQLQVANSLMNGVTLSTKLKDGVNFNVDDINFSPVL
GCLGSDCNKVSSRSAIEDLLFSKVKLSDVGFVEAYNNCTGGAEIRDLICV
QSYNGIKVLPPLLSENQISGYTLAATSASLFPPWSAAAGVPFYLNVQYRI
NGIGVTMDVLSQNQKLIANAFNNALGAIQEGFDATNSALVKIQAVVNANA
EALNNLLQQLSNRFGAISSSLQEILSRLDALEAQAQIDRLINGRLTALNA
YVSQQLSDSTLVKFSAAQAMEKVNECVKSQSSRINFCGNGNHIISLVQNA
PYGLYFIHFSYVPTKYVTAKVSPGLCIAGDRGIAPKSGYFVNVNNTWMFT
GSGYYYPEPITGNNVVVMSTCAVNYTKAPDVMLNISTPNLPDFKEELDQW
FKNQTSVAPDLSLDYINVTFLDLQDEMNRLQEAIKVLNQSYINLKDIGTY
EYYVKWPWYVWLLIGFAGVAMLVLLFFICCCTGCGTSCFKKCGGCCDDYT
GHQELVIKTSHDD
----+----1----+----2----+----3----+----4----+----5
Hydropathies
Home
Imprint
© 2007-2017
Dr. Katja Kapp
, Kassel &
thpr.net e. K.
, Dresden, Germany, last update 2010-06-11